Trial Profile
A PK Evaluation of Three Times Daily Dosing of UT-15C SR Tablets in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors United Therapeutics Corporation
- 30 Apr 2015 New trial record